Zhong Huijuan Net Worth, Age, Family & Biography $5.8 B Real Time Net Worth #288 in the world today

Avan Parvadiya — Sat, 02 Mar 2024 09:25:50 +0000

About Zhong Huijuan

Zhong Huijuan is a billionaire pharmaceutical executive from China and the world’s richest woman who made her money on her own. She is Hansoh Pharmaceutical’s chair, CEO, and founder. The company has its headquarters in Lianyungang and is listed on the Hong Kong Stock Exchange. She owns 66% of the company, making her the majority shareholder.

Zhong Huijuan, CEO of Hansoh Pharmaceutical Group Co. Ltd.

Zhong Huijuan Education

Zhong went to Jiangsu Normal University to study chemistry and received his degree in July 1982. He was born in Lianyungang, Jiangsu Province. After that, she held a position as a teacher of chemistry at Yan’an Middle School in Lianyungang. Sun Piaoyang, her husband, was in charge of a pharmaceutical factory owned by the state in the same city at the same time.

Zhong Huijuan Career

Sun and a Hong Kong investor established Hansoh Pharmaceutical Group in 1995 as a new pharmaceutical company. But since Sun actually worked at the state-claimed plant, he wound up excessively occupied to deal with the new organisation. This was Zhong’s chance to enter the drug business: She quit her job as a teacher to run the new business she started.

At first, the company only had about ten employees, but it quickly expanded and had a revenue of US$4.5 million by 1997. Zhong reinvests 5% of sales revenue into research and development to develop antibiotics, cancer treatments, psychotropic, endocrine, and gastrointestinal medications. Later, the research and development budget increased to nearly 10% of revenue, which is unusually high for a Chinese pharmaceutical company.

Zhong Huijuan Facts

During the COVID-19 pandemic in 2020, her wealth increased substantially. According to Forbes and Hurun, she was the 9th richest woman in the world that year, and she was also China’s 20th richest person.

Zhong Huijuan (2nd L), Chairwoman of Hansoh Pharmaceutical Group Co., Ltd., and Li Xiaojia (2nd R), chief executive of the Hong Kong Stock Exchange, attend the company’s listing ceremony at the Hong Kong Stock Exchange (HKEX) on April 14, 2019 in Hong Kong, China.